Re-Watch Our Webinar Series With The Primary Care Cardiovascular Society
Best Practice and the Primary Care Cardiovascular Society are delighted to have brought you a five part online education series consisting of live and on-demand webinars (June-August 2020).
Each webinar was delivered live on Tuesday nights between 7 – 8pm and have since been made available on demand through the Best Practice and the Primary Care Cardiovascular Society websites.
Cardiovascular experts who examined hypertension, lipids, Heart Failure, AF and Cardio-diabetes during and post COVID-19. Speakers included: Matthew Fay, Derek Connolly, Jim Moore, Ahmet Fuat and Kevin Fernando.
“Great job really good webinar!” - Brand Manager, Bayer
“It was a really good webinar from both Jim and Ahmet. Very useful content and interesting points raised. A lot to cover in a very short period of time.”
At the Heart of Diabetes - Tuesday, August 25, 2020 · 7:00 PM
Tues Aug 25th at 7:00 PM
Presented by: Kevin Fernando, GP Partner and GP with Specialist Interest in Diabetes & Medical Education
Cardiovascular disease is the leading cause of death in people living with type 2 diabetes. Since concerns were highlighted with rosiglitazone, it was made mandatory for all new diabetes drugs to prove their cardiovascular safety.
Somewhat unexpectedly, not only was cardiovascular safety established with certain newer diabetes drugs but also cardiovascular superiority compared to placebo i.e. significant reductions in major adverse cardiovascular events.
This webinar will summarise key take-home messages from all the published diabetes cardiovascular outcome studies to date, how these studies have changed guidelines and what the implications are for primary care.
Delivery of this webinar is supported by Data4NHS.
What’s New in the World of Lipid Management; a Guide to the Future - Tuesday, August 18, 2020 · 7:00 PM
Tues Aug 18th at 7:00 PM
Presented by: Dr Derek Connolly, Consultant Interventional Cardiologist
There is now categorical evidence that lowering LDL cholesterol reduces major adverse cardiovascular events in patients who have had previous events. Historically we have only had statins but more recently we have had the benefit of ezetimibe and the PCSK9 inhibitors. Soon there will be a fourth agent to lower LDL-cholesterol called bempedoic acid. There are also therapies coming to reduce lipoprotein [a]. The REDUCEIT study suggested that highly concentrated fish oil may also have a role.
This all suggests that cholesterol reduction has become easier and is more suited to whole populations because of the variety of therapies available. There is also increasing evidence that lifetime exposure to high LDL levels is more important than short time exposure. It therefore makes sense that long-term exposure to cholesterol reducing agents also gives better results.
Using molecular biology techniques there is evidence that polygenic polymorphisms account from most of the high-risk patients. Increasingly molecular biology will have a role to play and identifying those at highest risk. We have therefore come along way in cholesterol management with the promise of more therapies to come.
Delivery of this webinar is supported by Sanofi.
Sanofi have had no input into the selection of speaker or content.
Current Diagnosis and Management of Heart Failure
Tues Jul 28th at 7:00PM
Presented by: Dr Jim Moore, GP, The Stoke Road Surgery and Professor Ahmet Fuat, Professor of Primary Care Cardiology and GPSI Cardiology, Durham University and Carmel Medical Practice
Key learning points:
- Implementation of NICE guidance
- Providing heart failure services in a pandemic
- Expanding role of primary care - covering the new QoF indicators
Managing Patients with Atrial Fibrillation during a Pandemic
Tues Jul 14th at 7:00PM
Presented by Ahmet Fuat, Professor of Primar Care Cardiology and GPSI Cariology, Durham University and Carmel Medical Practice
The second webinar in our new Best Practice and PCCS series will be on 'Managing Patients with Atrial Fibrillation during a Pandemic'.
Key learning points:
- Diagnosis of AF
- National Targets for prevalence and oral anticoagulation
Stroke prevention including practical considerations of switching warfarin to a DOA
Bayer are kindly sponsoring this webinar, however have had no input into the selection of speakers or content.
Blood Pressure - Part of our A-B-Cs
Recorded: Tue Jun 30 at 7:00 PM
Presented by: Matthew Fay, Clinical Chief Executive and GP, Affinity Care PCN and The Willows Medical Practice
The first webinar in our new Best Practice and PCCS series.
With a major national campaign to fight excess CVD mortality, blood pressure management is centre stage once more.
However we are in a new world and a changing NHS since the global pandemic, so how do we find those at risk and how do we treat and monitor them?
Dr Fay endeavours to give some solutions to these problems. The session shows new possible pathways of care and explain the reasons for variations from previous ideas.